Multiple sclerosis: Geoepidemiology, genetics and the environment

Autoimmunity Reviews

Volumn 9, Issue 5, 2010, Pages

  Milo, Ron ^a   Kahana, Esther ^a,b  

^a BARZILAI MEDICAL CENTER   (Israel)

^b The Israeli National MS Registry (INMSR)   (Israel)

Author keywords

Environmental; Epidemiology; Genetic; Immigration; Multiple sclerosis; Risk factors

Indexed keywords

VITAMIN D;

AUTOIMMUNE DISEASE; DEGENERATIVE DISEASE; DEMYELINATING DISEASE; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS; GENETIC SUSCEPTIBILITY; GEOGRAPHIC DISTRIBUTION; HUMAN; HYGIENE; IMMIGRATION; INFECTIOUS MONONUCLEOSIS; LATENT VIRUS INFECTION; MULTIPLE SCLEROSIS; PERSISTENT VIRUS INFECTION; RELAPSE; REMISSION; REVIEW; ULTRAVIOLET RADIATION;

ANIMALS; AUTOIMMUNE DISEASES; DISEASE SUSCEPTIBILITY; ENVIRONMENT; HERPESVIRUS 4, HUMAN; HUMANS; MICE; MULTIPLE SCLEROSIS; PREVALENCE; RISK FACTORS; ULTRAVIOLET RAYS; VITAMIN D;

EID: 77649237783     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2009.11.010     Document Type: Review

References (41)

1. Compston A., Confavreux C., Lassmann H., McDonald I., Miller D., Noseworthy J., et al. McAlpine's multiple sclerosis (2006), Churchill Livingstone/Elsevier, Philadelphia
2. Rosati G. The prevalence of multiple sclerosis in the world: an update. Neurol Sci 22 (2001) 117-139
3. Kurtzke J.F. Epidemiology and etiology of multiple sclerosis. Phys Med Rehabil Clin North Am 16 (2005) 327-349
4. Granieri E., Casetta I., Govoni V., Tola M.R., Marchi D., Murgia S.B., et al. The increasing incidence and prevalence of MS in a Sardinian province. Neurology 55 (2000) 842-848
5. Chan W.W. Eskimos and multiple sclerosis (letter). Lancet 1 (1977) 1370
6. Bulman D.E., and Ebers G.C. The geography of MS reflects genetic susceptibility. J Trop Geogr Neurol 2 (1992) 66-72
7. Morario M., and Linden M. Multiple sclerosis in American blacks. Acta Neurol Scand 62 (1980) 180-187
8. Miller D.H., Hammond S.R., McLeod J.G., Purdie G., and Skegg D.C.G. Multiple sclerosis in Australia and New Zealand: are the determinants genetic or environmental. J Neurol Neurosurg Psychiatry 53 (1990) 903-905
9. Gronlie S.A., Myrvoll E., Hansen G., Gronning M., and Mellgren S.I. Multiple sclerosis in North Norway, and first appearance in an indigenous population. J Neurol 247 (2000) 129-133
10. Hawkes C.H., and Macgregor A.J. Twin studies and the heritability of MS: a conclusion. Mult Scler 15 (2009) 661-667
11. Dyment D.A., Sadovnick D., and Ebers G.C. Genetics of multiple sclerosis. Hum Mol Genet 6 (1997) 1693-1698
12. Sawcer S., Goodfellow P.N., and Compston A. The genetic analysis of multiple sclerosis. Trend Genet 13 (1997) 234-239
13. Carton H., Vlietinck R., Debrutne J., De Keyser J., D'Hooghe M.B., Loos R., et al. Risk of multiple sclerosis in relatives of patients in Fanders, Belgium. J Neurol Neurosurg Psychiatry 62 (1997) 329-333
14. Hohlfeld R. ECTRIMS lecture: future challenges in MS. Mult Scler 15 Suppl 2 (2009) S8-S9
15. Kahana E., Zilber N., Abrahamson J.H., Biton V., Leibowitz Y., and Abramsky O. Multiple sclerosis: genetic versus environmental aetiology: epidemiology in Israel updated. J Neurol 241 (1996) 341-346
16. Elian M., and Dean G. Multiple sclerosis among the United Kingdom-born children of immigrants from West Indies. J Neurol Neurosurg Psychiatry 50 (1987) 327-332
17. Gale C.R., and Martyn C.N. Migrant studies in multiple sclerosis. Prog Neurobiol 47 (1995) 425-448
18. Dean G. Annual incidence, prevalence and mortality of multiple sclerosis in white South-African born and in white immigrants to South Africa. BMJ 2 (1967) 724-730
19. Hammond S.R., English D.R., and McLeon J.G. The age range of risk of developing multiple sclerosis. Evidence from a migrant population in Australia. Brain 123 (2000) 968-974
20. Alter M., Kahana E., and Lowenson R. Migration and risk of multiple sclerosis. Neurology 28 (1978) 1089-1093
21. Kahana E., Alter M., Zilber N., and The Israeli MS Study Group. Environmental factors determine multiple sclerosis risk in migrant to Israel. Mult Scler 14 suppl 1 (2008) S69-S70
22. Wallin M.T., Page W.F., and Kurtzke J.F. Multiple sclerosis in US veterans of the Vietnam era and later military service: race sex and geography. Ann Neurol 55 (2004) 65-71
23. Pugliatti M., Rosati G., Carton H., Riise T., Drulovic J., Vécsei L., et al. The epidemiology of multiple sclerosis in Europe. Eur J Neurol 13 (2006) 700-722
24. Acheson E.D. Epidemiology of multiple sclerosis. Br Med Bull 33 (1977) 9-14
25. Marrie R.A. Environmental risk factors in multiple sclerosis aetiology. Lancet Neurol 3 (2004) 709-718
26. Ascherio A., and Munger K.L. Environmental risk factors for multiple sclerosis. Part II: noninfectious factors. Ann Neurol 61 (2007) 504-513
27. Goldacre M.J., Seagreatt V., Yeates D., and Acheson E.D. Skin cancer in people with multiple sclerosis: a record linkage study. J Epidemiol Community Health 58 (2004) 142-144
28. Alter M., Kahana E., Zilber N., Miller A., and The Israeli MS study group. Multiple sclerosis frequency in Israel's diverse populations. Neurology 66 (2006) 1061-1066
29. Smolders J., Peelen E., Thewissen M., et al. The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis. Autoimmun Rev 8 (2009) 621-626
30. Willer C.J., Dyment D.A., Sadovnick A.D., Rothwell P.M., Murray T.J., Ebers G.C., et al. Timing of birth and risk of multiple sclerosis: population based study. Br Med J 330 (2005) 120-124
31. Lewy H., Rotstein A., Kahana E., Marrosu M.G., Cocco E., and Laron Z. Juvenile multiple sclerosis similar to type I diabetes mellitus has a seasonality of month of birth which differs from that in the general population. J Pediatr Endocrinol Metab 21 (2008) 473-477
32. Ascherio A., and Munger K.L. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol 61 (2007) 288-299
33. Hughes L.E., Smith P.A., Bonel S., Natt R.S., Wilson C., Rashid T., et al. Cross reactivity between related sequences found in Acinetobacter spp., Pseudomonas aeruginosa, myelin basic protein and myelin oligodendrocyte glycoprotein in multiple sclerosis. J Neuroimmunol 144 (2003) 105-115
34. Sewell D.L., Reinke E.K., Hogan L.H., Sandor M., and Fabry S. Immunoregulation of CNS autoimmunity by helminth and mycobacterial infections. Immunol Lett 82 (2002) 101-110
35. Zilber N., Kutai-Berman M., Kahana E., and Korczyn A.D. Multiple sclerosis and birth order. Acta Neurol Scand 78 (1988) 313-317
36. Korn-Lubetzki I., Kahana E., Cooper G., and Abramsky O. Activity of multiple sclerosis during pregnancy and puerperium. Ann Neurol 16 (1984) 229-231
37. Barcellos L.P., Kamdar B.B., Ramsay P.P., DeLoa C., Lincoln R.R., Caillier S., et al. Clustering of autoimmune diseases in families with a high-risk for multiple sclerosis: a descriptive study. Lancet Neurol 5 (2006) 824-931
38. Ramagopalan S.V., Dyment D.A., Valdar W., Herrera B.M., Criscuoli M., Yee I.M., et al. Autoimmune disease in families with multiple sclerosis: a population-based study. Lancet Neurol 6 (2007) 604-610
39. Gilden D.H. Infective causes of multiple sclerosis. Lancet Neurol 4 (2005) 195-202
40. Waxsman S.G. Multiple sclerosis as a neuronal disease (2005), Elsevier Academic Press, Boston
41. Vartanian T.K. MS as a neurodegenerative disease (a thought experiment): the clinical evidence. Adv Stud Med 8 (2008) 305-308